US4680172A
(en)
*
|
1985-03-05 |
1987-07-14 |
Ciba-Geigy Corporation |
Devices and methods for treating memory impairment
|
US4765985A
(en)
*
|
1985-03-05 |
1988-08-23 |
Ciba-Geigy Corporation |
Devices and methods for treating memory impairment
|
US4855290A
(en)
|
1985-05-10 |
1989-08-08 |
State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research |
Derivatives of quinuclidine
|
US4666926A
(en)
*
|
1986-02-27 |
1987-05-19 |
Warner-Lambert Company |
Transdermal formulations
|
US4908027A
(en)
*
|
1986-09-12 |
1990-03-13 |
Alza Corporation |
Subsaturated transdermal therapeutic system having improved release characteristics
|
US4861800A
(en)
*
|
1987-08-18 |
1989-08-29 |
Buyske Donald A |
Method for administering the drug deprenyl so as to minimize the danger of side effects
|
DE3729299A1
(de)
*
|
1987-09-02 |
1989-03-23 |
Beiersdorf Ag |
Transdermales therapeutisches system
|
US6107499A
(en)
*
|
1988-02-26 |
2000-08-22 |
Neuromedica, Inc. |
Dopamine analog amide
|
US5994392A
(en)
|
1988-02-26 |
1999-11-30 |
Neuromedica, Inc. |
Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
|
GB8807504D0
(en)
*
|
1988-03-29 |
1988-05-05 |
Sandoz Ltd |
Improvements in/relating to organic compounds
|
US5075314A
(en)
*
|
1988-10-27 |
1991-12-24 |
Leitman Esther M |
Antimicturition composition and novel method
|
US5075312A
(en)
*
|
1988-10-27 |
1991-12-24 |
Leitman Esther M |
Novel anti-micturition composition and method
|
DE3843239C1
(no)
|
1988-12-22 |
1990-02-22 |
Lohmann Therapie Syst Lts |
|
DE3843238C1
(no)
*
|
1988-12-22 |
1990-02-22 |
Lohmann Therapie Syst Lts |
|
CA2012192A1
(en)
*
|
1989-03-28 |
1990-09-28 |
Munir A. Hussain |
Intranasal administration of physostigmine and arecoline
|
NZ237241A
(en)
*
|
1990-03-02 |
1993-11-25 |
Pharmetrix Corp |
Method for increasing the storage stability of physostigmine
|
WO1991015176A1
(en)
*
|
1990-04-06 |
1991-10-17 |
Pharmetrix Corporation |
Device and method for enhanced administration of physostigmine
|
US5931774A
(en)
*
|
1991-06-14 |
1999-08-03 |
Proxima Therapeutics, Inc. |
Inflatable devices for tumor treatment
|
US5429582A
(en)
*
|
1991-06-14 |
1995-07-04 |
Williams; Jeffery A. |
Tumor treatment
|
GB9118028D0
(en)
*
|
1991-08-21 |
1991-10-09 |
Secr Defence Brit |
Improved transdrmal formulations
|
TW224048B
(no)
*
|
1992-03-30 |
1994-05-21 |
Hoechst Roussel Pharma |
|
US5596007A
(en)
*
|
1992-05-18 |
1997-01-21 |
Pharmaco Behavioral Associates, Inc. |
Therapeutic method to alleviate the craving associated with cessation of tobacco with cotinine
|
US5643928A
(en)
*
|
1992-10-21 |
1997-07-01 |
Pharmaco Behavioral Associates, Inc. |
Human body weight management
|
US5612357A
(en)
*
|
1992-05-18 |
1997-03-18 |
Pharmaco Behavioral Associates, Inc. |
Use of cotinine to assist in the cessation of tobacco smoking
|
US5869505A
(en)
*
|
1993-02-02 |
1999-02-09 |
Keenan; Robert M. |
Nicotine metabolites and nicotine dependence
|
DE4238223C1
(de)
*
|
1992-11-12 |
1994-05-26 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung
|
US5573774A
(en)
*
|
1993-02-02 |
1996-11-12 |
Keenan; Robert M. |
Nicotine metabolites, nicotine dependence and human body weight
|
DE4313928C2
(de)
*
|
1993-04-28 |
1996-09-19 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung
|
DE4342174C1
(de)
*
|
1993-12-10 |
1995-05-11 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung
|
JP3908795B2
(ja)
*
|
1994-11-29 |
2007-04-25 |
久光製薬株式会社 |
ケトチフェン含有経皮投与製剤
|
US5861431A
(en)
*
|
1995-06-07 |
1999-01-19 |
Iotek, Inc. |
Incontinence treatment
|
DE19533089C1
(de)
*
|
1995-09-07 |
1997-05-22 |
Hexal Ag |
Tacrin-Pflaster
|
US5795909A
(en)
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
US6576636B2
(en)
|
1996-05-22 |
2003-06-10 |
Protarga, Inc. |
Method of treating a liver disorder with fatty acid-antiviral agent conjugates
|
US6479074B2
(en)
|
1996-10-24 |
2002-11-12 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
US6572880B2
(en)
|
1996-10-24 |
2003-06-03 |
Pharmaceutical Applications Associates Llc |
Methods and transdermal compositions for pain relief
|
US6290986B1
(en)
|
1996-10-24 |
2001-09-18 |
Pharmaceutical Applications Associates, Llc |
Method and composition for transdermal administration of pharmacologic agents
|
US5977174A
(en)
*
|
1997-11-26 |
1999-11-02 |
Neuromedica, Inc. |
Cholinergic compositions and uses thereof
|
US6197764B1
(en)
|
1997-11-26 |
2001-03-06 |
Protarga, Inc. |
Clozapine compositions and uses thereof
|
US6146656A
(en)
*
|
1998-01-22 |
2000-11-14 |
Nitto Denko Corporation |
Percutaneous absorption preparation
|
US6225444B1
(en)
|
1998-02-10 |
2001-05-01 |
Protarga, Inc. |
Neuroprotective peptides and uses thereof
|
JP3987655B2
(ja)
*
|
1998-03-03 |
2007-10-10 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
抗痴呆薬を含有した経皮適用製剤又は坐剤
|
US7235583B1
(en)
|
1999-03-09 |
2007-06-26 |
Luitpold Pharmaceuticals, Inc., |
Fatty acid-anticancer conjugates and uses thereof
|
CN1384825A
(zh)
|
1999-08-31 |
2002-12-11 |
马克西亚药品公司 |
亚苄基-噻唑烷二酮及其类似物以及它们在治疗糖尿病中的应用
|
US7077859B2
(en)
|
2000-12-22 |
2006-07-18 |
Avantec Vascular Corporation |
Apparatus and methods for variably controlled substance delivery from implanted prostheses
|
IL157740A0
(en)
|
2001-03-07 |
2004-03-28 |
Incyte San Diego Inc |
Heterocyclic derivatives and pharmaceutical compositions containing the same
|
JP2004523571A
(ja)
*
|
2001-03-08 |
2004-08-05 |
マキシア・ファーマシューティカルズ・インコーポレイテッド |
Rxr活性化分子
|
CA2340824A1
(en)
*
|
2001-03-14 |
2002-09-14 |
Ibm Canada Limited-Ibm Canada Limitee |
Method and system for application behavior analysis
|
JP2005500988A
(ja)
*
|
2001-03-23 |
2005-01-13 |
ルイトポルド・ファーマシューティカルズ・インコーポレーテッド |
脂肪族アミン薬物複合体
|
JP4634694B2
(ja)
|
2001-03-23 |
2011-02-16 |
ルイトポルド・ファーマシューティカルズ・インコーポレーテッド |
脂肪アルコール薬物複合体
|
WO2003016267A1
(en)
*
|
2001-08-17 |
2003-02-27 |
Incyte San Diego Incorporated |
Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia
|
WO2003028723A1
(fr)
*
|
2001-09-27 |
2003-04-10 |
Saitama Daiichi Pharmaceutical Co., Ltd. |
Compositions pharmaceutiques destinee a l'absorption par voie percutanee contenant des derives d'imidazopyridine fondus
|
EP1456187A4
(en)
*
|
2001-11-15 |
2005-02-09 |
Incyte San Diego Inc |
N-SUBSTITUTED HETEROCYCLES FOR THE TREATMENT OF HYPERCHOLESTERINEMIA, DYSLIPIDEMIA AND OTHER METABOLIC DISORDER, CANCER AND OTHER DISEASES
|
US8529807B2
(en)
|
2002-01-17 |
2013-09-10 |
Lts Lohmann Therapie-Systeme Ag |
Method for neutralizing or recycling carrier materials for film-like coatings
|
US7102000B2
(en)
*
|
2002-03-08 |
2006-09-05 |
Incyte San Diego Inc. |
Heterocyclic amide derivatives for the treatment of diabetes and other diseases
|
US7196108B2
(en)
*
|
2002-03-08 |
2007-03-27 |
Incyte San Diego Inc. |
Bicyclic heterocycles for the treatment of diabetes and other diseases
|
US20040087576A1
(en)
*
|
2002-11-05 |
2004-05-06 |
Haracz John L. |
Antimnemonic therapy for hypermemory syndromes
|
WO2004066952A2
(en)
*
|
2003-01-29 |
2004-08-12 |
Incyte Corporation |
Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
|
BRPI0409501A
(pt)
*
|
2003-04-18 |
2006-04-18 |
Incyte San Diego Inc |
compostos isocromanos substituìdos para o tratamento de desordens metabólicas, de cáncer e de outras doenças
|
DE10338174A1
(de)
|
2003-08-20 |
2005-03-24 |
Lts Lohmann Therapie-Systeme Ag |
Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
|
TWI372066B
(en)
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
US20050182044A1
(en)
*
|
2004-02-17 |
2005-08-18 |
Bruinsma Gosse B. |
Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
|
CA2508585A1
(en)
*
|
2004-06-01 |
2005-12-01 |
Axonyx, Inc. |
Transdermal delivery system for treatment of cognitive disorders
|
US20050272804A1
(en)
*
|
2004-06-08 |
2005-12-08 |
Axonyx, Inc |
Methods of delaying Alzheimer's disease progression using a beta-amyloid precursor protein inhibitor and a HMG CoA reductase inhibitor
|
JP2008519847A
(ja)
*
|
2004-11-10 |
2008-06-12 |
ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク |
運動障害の治療方法
|
JP2007308403A
(ja)
*
|
2006-05-17 |
2007-11-29 |
Kenji Yoshida |
皮膚外用剤
|
US20070287727A1
(en)
*
|
2006-06-08 |
2007-12-13 |
Jacob Hiller |
Anti-Nicotine Treatment
|
WO2009142968A2
(en)
*
|
2008-05-20 |
2009-11-26 |
Olema Pharmaceuticals, Inc. |
Valproic acid salts
|
WO2010048572A1
(en)
|
2008-10-23 |
2010-04-29 |
Cornell University |
A novel anti-viral method
|
LT2968992T
(lt)
|
2013-03-15 |
2020-03-25 |
Tonix Pharma Holdings Limited |
Ciklobenzaprino hidrochlorido ir manitolio eutektinės kompozicijos
|
SG11202004799TA
(en)
|
2017-12-11 |
2020-06-29 |
Tonix Pharma Holdings Ltd |
Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions
|